Director, Market Access Marketing: Precision & Prostate

6077-Johnson & Johnson HCS Inc. Legal Entity

Horsham (PA)

On-site

USD 164,000 - 283,000

Full time

13 days ago

Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Benefits offered by this job

Vacation time 120 hrs/yr

Sick time 40 hrs/yr (Colorado 48; Wash

Holiday pay

Job summary

Johnson & Johnson Health Care Systems Inc. in Horsham, PA, is seeking a Director, Market Access Marketing, Precision Medicine & Solid Tumor Pipeline to drive access strategy and launch readiness for late-stage asset programs.

The role collaborates with PS&E Precision Medicine and cross-functional teams to shape testing, coverage, and reimbursement plans. The incumbent will coordinate with NPBD, Global Market Access, and inline teams to ensure successful market entry for Precision Medicine assets

Qualifications

Bachelor's degree required; advanced degree preferred.
10+ years of experience in biopharmaceutical, diagnostic, medical device, or related healthcare industries, including significant Market Access.
Strong understanding of U.S. payer, provider, reimbursement, and healthcare delivery dynamics.
Demonstrated ability to influence and lead across complex, matrixed organizations.
Oncology experience required.
Willingness to travel up to 20%.
Preferred Precision Medicine, companion diagnostic, biomarker testing, NGS, or diagnostic Market Access experience.
Solid Tumor and/or Prostate cancer experience.
Late-stage pipeline and launch-readiness experience.
Prior customer-facing or account management experience.
People leadership experience.

Responsibilities

Lead Market Access strategy, go-to-market planning, and launch readiness for late-stage Solid Tumor Prostate assets.
Serve as the primary Market Access partner to the PS&E Precision Medicine team.
Embed Precision Medicine Market Access capabilities, insights, tools, and best practices across brand‑aligned Market Access teams.
Translate evolving payer, provider, laboratory benefit manager, and testing‑market dynamics into actionable strategies that improve testing access, patient identification, and treatment adoption.
Partner across Global Market Access, NPBD, Medical Affairs, Value & evidence, Commercial, and Brand teams to shape Market Access requirements for pipeline assets with Precision Medicine components.